C07C57/42 - CPC Classification Index

#1

20250271754

2025-08-28

SEMICONDUCTOR PHOTORESIST COMPOSITIONS AND METHODS OF FORMING PATTERNS USING THE COMPOSITION

#2

20250059177

2025-02-20

Anti-inflammatory Compounds, Pharmaceutical Compositions, and Treatment Methods

#3

20250011272

2025-01-09

LONG-CHAIN COMPOUND THAT ACTS ON ACLY, PREPARATION METHOD THEREFOR AND USE THEREOF

#4

20240368065

2024-11-07

CITRACONIC ACID AND DERIVATIVES THEREOF FOR USE AS A MEDICAMENT

#5

20240199523

2024-06-20

Salts and esters of APX3330 and therapeutic uses thereof

#6

20240101505

2024-03-28

SALTS AND ESTERS OF APX3330 AND THERAPEUTIC USES THEREOF

#7

20230314934

2023-10-05

PHOTOACTIVE COMPOUNDS, PHOTORESIST COMPOSITIONS INCLUDING THE SAME, AND PATTERN FORMATION METHODS

#8

20210261495

2021-08-26

Compositions and methods of using itaconic acid derivatives

#9

20210101861

2021-04-08

NOVEL REXINOID COMPOUNDS AND METHODS OF USING REXINOID COMPOUNDS FOR TREATING METABOLIC DISORDERS AND CANCER

#10

20210002202

2021-01-07

Substituted Aromatic Compounds and Pharmaceutical Uses Thereof

#11

20200181455

2020-06-11

NANO-ADHESIVE AND SURFACE PRIMER COMPOUND AND USE THEREOF

#12

20200017432

2020-01-16

Substituted aromatic compounds for the treatment of pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis

#13

20190262497

2019-08-29

Therapeutic acrylates as enhanced medical adhesives

#14

20190039989

2019-02-07

Fatty acid compound, preparation method therefor and use therefor

#15

20180201565

2018-07-19

Rexinoid compounds and methods of using rexinoid compounds for treating metabolic disorders and cancer

#16

20180162799

2018-06-14

Substituted aromatic compounds and pharmaceutical uses thereof

#17

20180148401

2018-05-31

Compounds and methods of use thereof for treating tumors

#18

20180134649

2018-05-17

Substituted aromatic compounds for the treatment of pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis

#19

20180030352

2018-02-01

REACTIVE PERPENDICULAR ALIGNED MATERIAL, LIQUID CRYSTAL DISPLAY PANEL, AND METHOD OF LIQUID CRYSTAL ALIGNMENT

#20

20170369417

2017-12-28

TAK1 kinase inhibitors, compositions, and uses related thereto

#21

20170209499

2017-07-27

Propolis and Extracts Thereof for the Treatment of Skin Cancers and Improvement of Skin Health

#22

20170022136

2017-01-26

Phenyl (meth)acrylate production method and phenyl (meth)acrylate composition

#23

20160244396

2016-08-25

Phenyl (meth)acrylate production method and phenyl (meth)acrylate composition

#24

20160237012

2016-08-18

ANTICANCER AGENTS AND PROCESS OF MAKING THEREOF

#25

20160137921

2016-05-19

POLYMERIZABLE COMPOUND, AND LIQUID CRYSTAL COMPOSITION PRODUCED USING SAME

#26

20160122274

2016-05-05

Salts of sitagliptin, process from the preparation and pharmaceutical composition therefore

#27

20160023983

2016-01-28

Substituted aromatic compounds for the treatment pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis

#28

20150344440

2015-12-03

Compounds and methods of use thereof for treating tumors

#29

20150111749

2015-04-23

Use of sarmentine and its analogs for controlling plant pests

#30

20150094372

2015-04-02

Substituted aromatic compounds and pharmaceutical uses thereof

#31

20140323457

2014-10-30

BETA-O/S/N FATTY ACID BASED COMPOUNDS AS ANTIBACTERIAL AND ANTIPROTOZOAL AGENTS

#32

20140249199

2014-09-04

TAK1 kinase inhibitors, compositions, and used related thereto

#33

20140221330

2014-08-07

NDM inhibitor

#34

20140094519

2014-04-03

Lipoxin analogs as novel inhibitors of angiogenesis

#35

20140073791

2014-03-13

Salts of sitagliptin, process for the preparation and pharmaceutical composition therefore

#36

20130338329

2013-12-19

Radically curable compound, cured product thereof, and method for producing the compound

#37

20130281294

2013-10-24

Use of sarmentine and its analogs for controlling plant pests

#38

20120088784

2012-04-12

Substituted aromatic compounds and pharmaceutical uses thereof

#39

20120071457

2012-03-22

Metallo-β-lactamase inhibitors

#40

20120035257

2012-02-09

Histone Deacetylase Inhibitors

#41

20110287535

2011-11-24

Histone deacetylase inhibitors

#42

20110152226

2011-06-23

Development of new selective estrogen receptor modulators

#43

20110105544

2011-05-05

CARBOXYLIC DERIVATIVES FOR USE IN THE TREATMENT OF CANCER

#44

20110021358

2011-01-27

Use of sarmentine and its analogs for controlling plant pests

#45

20090259065

2009-10-15

Methods of making organic compounds by metathesis and hydrocyanation

#46

20090105288

2009-04-23

Carbon linked modulators of gamma-secretase

#47

20080312324

2008-12-18

Treatment of lung cells with histone deacetylase inhibitors

#48

20080214609

2008-09-04

Development of new selective estrogen receptor modulators

#49

20080167493

2008-07-10

METHODS FOR CONVERSION OF TYROSINE TO P-HYDROXYSTYRENE AND P-HYDROXYCINNAMIC ACID

#50

20080090825

2008-04-17

Metallo-β-lactamase inhibitors

#51

20080004455

2008-01-03

Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same

#52

20070299114

2007-12-27

Biaryl Derivatives

#53

20060183737

2006-08-17

Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists

#54

20050254319

2005-11-17

Polymer bound donor-acceptor-donor compounds and their use in a 3-dimensional optical memory

#55

20050227967

2005-10-13

Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists

#56

20050176689

2005-08-11

Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same

#57

20050171208

2005-08-04

Histone deacetylase inhibitors

#58

20050113453

2005-05-26

Development of new selective estrogen receptor modulators

#59

20050107348

2005-05-19

Histone deacetylase inhibitors

#60

20050038119

2005-02-17

2-aryl-propionic acids and pharmaceutical compositions containing them